Pulmonary Thromboendarterectomy for Pulmonary Hypertension Before Considering Transplant

REFERENCES

1. ↵
   1. Pengo V,
   2. Lensing AW,
   3. Prins MH,
   4. et al.

   Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 5 27; 350 22: 2257- 2264. pmid:15163775

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Wilkens H,
   2. Lang I,
   3. Behr J,
   4. et al.

   Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations of the Cologne Consensus Conference 2011. Int J Cardiol. 2011 12; 154 Suppl 1: S54- S60. doi: 10.1016/S0167-5273(11)70493-4. pmid:22221974

   OpenUrlCrossRefPubMed
3. ↵
   1. Marshall PS,
   2. Kerr KM,
   3. Auger WR

   Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2013 12; 34 4: 779- 797. doi: 10.1016/j.ccm.2013.08.012. pmid:24267304

   OpenUrlCrossRefPubMed
4. ↵
   1. Condliffe R,
   2. Kiely DG,
   3. Gibbs JS,
   4. et al.

   Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008 5 15; 177 10: 1122- 1127. doi: 10.1164/rccm.200712-1841OC. pmid:18292468

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. D'Armini AM,
   2. Cattadori B,
   3. Monterosso C,
   4. et al.

   Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J of Cardiothorac Surg. 2000 12; 18 6: 696- 701; discussion 701-702. pmid:11113678

   OpenUrlCrossRefPubMed
6. ↵
   1. Jamieson SW,
   2. Kapelanski DP,
   3. Sakakibara N,
   4. et al.

   Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003 11; 76 5: 1457- 1462; discussion 1462-1464. pmid:14602267

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Fares WH,
   2. Heresi GA

   Chronic thromboembolic pulmonary hypertension: a worldwide view of how far we have come. Lung. 2016 6; 194 3: 483- 485. doi: 10.1007/s00408-016-9863-6. pmid:26926873

   OpenUrlCrossRefPubMed
8. ↵
   1. Suntharalingam J,
   2. Goldsmith K,
   3. Toshner M,
   4. et al.

   Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension. Respir Med. 2007 11; 101 11: 2254- 2262. pmid:17706409

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Corsico AG,
   2. D'Armini AM,
   3. Cerveri I,
   4. et al.

   Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med. 2008 8 15; 178 4: 419- 424. doi: 10.1164/rccm.200801-101OC. pmid:18556630

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Mayer E,
    2. Jenkins D,
    3. Lindner J,
    4. et al.

    Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011 3; 141 3: 702- 710. doi: 10.1016/j.jtcvs.2010.11.024. pmid:21335128

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Daniels LB,
    2. Krummen DE,
    3. Blanchard DG

    Echocardiography in pulmonary vascular disease. Cardiol Clin. 2004 8; 22 3: 383- 399, vi. pmid:15302359

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Freed DH,
    2. Thomson BM,
    3. Berman M,
    4. et al.

    Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011 2; 141 2: 383- 387. doi: 10.1016/j.jtcvs.2009.12.056. pmid:20471039

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Norfolk SG,
    2. Lederer DJ,
    3. Tapson VF

    Lung transplantation and atrial septostomy in pulmonary arterial hypertension. Clin Chest Med. 2013 12; 34 4: 857- 865. doi: 10.1016/j.ccm.2013.09.002. pmid:24267309

    OpenUrlCrossRefPubMed
14. ↵
    1. Weill D,
    2. Benden C,
    3. Corris PA,
    4. et al.

    A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015 1; 34 1: 1- 15. doi: 10.1016/j.healun.2014.06.014. pmid:25085497

    OpenUrlCrossRefPubMed
15. ↵
    1. Hill NS,
    2. Badesch DS,
    3. Benza RL,
    4. et al.

    Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration. Ann Am Thorac Soc. 2015 2; 12 2: 269- 273. doi: 10.1513/AnnalsATS.201501-020AS. pmid:25590376

    OpenUrlCrossRefPubMed